Skip to main content
Clinical Trials/ISRCTN54256247
ISRCTN54256247
Completed
Not Applicable

A randomised controlled trial to evaluate topical 10% metronidazole ointment for the treatment of perianal Crohn's disease

Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)0 sites30 target enrollmentSeptember 30, 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Crohn's disease
Sponsor
Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
Enrollment
30
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 30, 2005
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional

Investigators

Sponsor
Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)

Eligibility Criteria

Inclusion Criteria

  • 30 patients with peri\-anal Crohn's disease will be recruited throughout the course of the trial.

Exclusion Criteria

  • Not provided at time of registration

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Randomised Controlled Trial of the Use of Topical Application of Tranexamic Acid in Primary Total Hip Replacement. - (TRANX-H)Blood loss in total hip replacement in patient with ostoearthritis and rheumatoid arthritis.
EUCTR2009-012141-34-GBniversity Hospital of North Tees and Hartlepool150
Active, not recruiting
Not Applicable
Randomised Controlled Trial of the Use of Topical Application of Tranexamic Acid in Primary Cemented Total Knee Replacement (TRANX-K). - TRANX-KIn this study Tranexamic acid efficacy in reducing blood loss will be investigated in total knee replacement.Tranexamic acid will be applied topically to the exposed tissue around the knee joint prior to the wound closure and tourniquet release. It is anticipated that this method of administration will be quicker, easier and have less systemic side effect.MedDRA version: 9.1Level: LLTClassification code 10023227Term: Joint replacement
EUCTR2007-007813-35-GBniversity Hospital of North Tees and Hartlepool
Completed
Phase 3
The impact of Althaea officinalis formulation on controlling the symptoms of atopic dermatitisAtopic Eczema.Other atopic dermatitis
IRCT2016102323235N5Vice chancellor for research, Mashhad University of Medical Sciences40
Completed
Phase 2
Effect of topical formulation of Cinnamon essential oil in treatment of Acne
IRCT2016030726938N2Tehran University of Medical Sciences15
Not yet recruiting
Not Applicable
Evaluation of four types of therapies for the treatment of urogenital atrophy in postmenopausal womeIn postmenopausal women with symptoms of urogenital atrophyN95.2
RBR-2wjrp4Hospital da Mulher Prof. Dr. José Aristodemo Pinotti - CAISM Unicamp